Jane Street
OTLK icon

Jane Street’s Outlook Therapeutics OTLK Stock Holding History

Jane Street’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-104,662
Closed -$45.2K – 12611
2025
Q4 		$165K Buy
104,662
+78,837
+305% +$126K ﹤0.01% 9870
2025
Q3 		$27.4K Sell
25,825
-44,982
-64% -$77.8K ﹤0.01% 10478
2025
Q2 		$113K Buy
+70,807
New +$113K ﹤0.01% 8901
2025
Q1 		– Sell
-26,218
Closed -$49.6K – 10295
2024
Q4 		$49.6K Buy
26,218
+15,008
+134% +$61.7K ﹤0.01% 8971
2024
Q3 		$59.9K Buy
11,210
+1,001
+10% +$7.33K ﹤0.01% 9136
2024
Q2 		$75.3K Sell
10,209
-3,339
-25% -$26.8K ﹤0.01% 8827
2024
Q1 		$162K Buy
13,548
+10,904
+412% +$88.2K ﹤0.01% 8306
2023
Q4 		$20.8K Buy
+2,644
New +$22.4K ﹤0.01% 8903
2023
Q3 		– Sell
-1,182
Closed -$41.1K – 9166
2023
Q2 		$41.1K Buy
+1,182
New +$32.2K ﹤0.01% 8251
2023
Q1 		– Sell
-889
Closed -$19.2K – 9686
2022
Q4 		$19.2K Buy
889
+361
+68% +$7.85K ﹤0.01% 8620
2022
Q3 		$13K Buy
+528
New +$12.3K ﹤0.01% 9294
2022
Q2 		– Sell
-4,077
Closed -$145K – 10532
2022
Q1 		$145K Buy
+4,077
New +$127K ﹤0.01% 9260
2021
Q3 		– Sell
-3,198
Closed -$160K – 10510
2021
Q2 		$160K Buy
+3,198
New +$148K ﹤0.01% 8996
2019
Q4 		– Sell
-889
Closed -$26K – 5549
2019
Q3 		$26K Buy
+889
New +$34.3K ﹤0.01% 4942

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Jane Street's OTLK Position: Q1 2026 in Review

Jane Street sold out of Outlook Therapeutics (OTLK) in Q1 2026, closing a stake of 104,662 shares — an estimated $45.2K sold.

Jane Street first reported a position in OTLK in Q3 2019 and held it in 14 quarters. The position peaked at $165K in Q4 2025. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Jane Street reported no remaining Outlook Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 104,662 Outlook Therapeutics shares in Q1 2026, an estimated $45.2K.
  • Jane Street first reported a position in Outlook Therapeutics in Q3 2019 and held it in 14 quarters.
  • Jane Street's Outlook Therapeutics position peaked at $165K in Q4 2025.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.